Calithera Biosciences Cash Flow - Quarterly (NASDAQ:CALA)

Add to My Stocks
$4.95 $0.15 (3.13%) CALA stock closing price Sep 21, 2018 (Closing)

The Calithera Biosciences cash flow statement helps investors understand how well the company is managing its cash flows. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Calithera Biosciences profits one has to check the income statement and for Calithera Biosciences debt one has to check the balance sheet. Calithera Biosciences stock analysis shows negative net income cash flow of $-16.28M till 2018 Q2. This statement is important because profits alone cannot pay employees, or bills. Cash is required. Calithera Biosciences saw a inflow of $41.25M from investing activities till 2018 Q2.

View and download details of Calithera Biosciences cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities-22.16M-3.78M35.22M37.38M44.29M39.53M1.84M2.33M2.08M-
Cash From (used in) Discontinued Operations----------
Other Adjustments Net3.8M1.88M5.54M3.97M2.5M1.14M4.25M3.18M2.11M1.02M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.06M-0.02M-1.22M-0.68M-0.22M-0.05M-0.4M-0.23M-0.21M-0.16M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments41.32M21.19M-97.2M-116.4M-109.35M-76.91M24.1M20.72M12.51M9.58M
Other Cash Inflow (Outflow) from Investment Activities---0.39M-0.39M-0.39M-0.39M----
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares--122.94M121.18M120.95M120.57M11.81M7.25M4.17M4.24M
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year10.6M6.1M101.96M33.82M2.2M3.27M3.27M---
Cash & Equivalents at Year End56.31M55.28M48.47M39.41M57.99M89.07M10.6M11.6M7.32M12.16M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Calithera Biosciences stock price history provides insight into historical stock price fluctuations, and Calithera Biosciences stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Calithera Biosciences had a Net Change in Cash and Cash Equivalents of $7.39M in the latest quarter 2018 Q2. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Calithera Biosciences stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Calithera Biosciences reported a negative operating cash flow of $-34.39M till 2018 Q2 and has seen a decrease from the previous quarter. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $41.25M for CALA stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Calithera Biosciences spent $- from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Calithera Biosciences Cash Flow

Quarterly Cash Flow Statements For Calithera Biosciences Inc Peers

Bristol-Myers Squibb cash flow, MediWound cash flow, Merck cash flow, Pfizer cash flow, Recro Pharma cash flow